Adverse drug events in cost-effectiveness analyses of interventions for diabetic conditions: a scoping review protocol

The objective of this review is to provide an overview of adverse drug events in cost-effectiveness analyses related to the pharmacological treatments of diabetes and diabetes-related complications. INTRODUCTION: The inclusion of adverse drug events in cost-effectiveness analyses is recognized in he...

Descripción completa

Detalles Bibliográficos
Autores principales: Pesonen, Mari, Kankaanpää, Eila, Jylhä, Virpi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750098/
https://www.ncbi.nlm.nih.gov/pubmed/35916006
http://dx.doi.org/10.11124/JBIES-21-00460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750098/
https://www.ncbi.nlm.nih.gov/pubmed/35916006
http://dx.doi.org/10.11124/JBIES-21-00460

Ejemplares similares